Traditionally, genetic abnormalities detected by conventional karyotyping, fluorescence in situ hybridization, and polymerase chain reaction divided childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) into well-established genetic subtypes. This genetic classification has been prognostically relevant and thus used for the risk stratification of therapy. Recently, the introduction of genome-wide approaches, including massive parallel sequencing methods (whole-genome, -exome, and -transcriptome sequencing), enabled extensive genomic studies which, together with gene expression profiling, largely expanded our understanding of leukemia pathogenesis and its heterogeneity. Novel BCP-ALL subtypes have been described. Exact identification of recurrent genetic alterations and their combinations facilitates more precise risk stratification of patients. Discovery of targetable lesions in subsets of patients enables the introduction of new treatment modalities into clinical practice and stimulates the transfer of modern methods from research laboratories to routine practice.

Childhood Leukaemia Investigation Prague Prague Czech Republic

Department of Pediatric Hematology and Oncology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Pui CH, Relling MV, Downing JR: Acute lymphoblastic leukemia. PubMed DOI

Harrison CJ, Haas O, Harbott J, et al. : Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster study group. PubMed DOI

Iacobucci I, Mullighan CG: Genetic Basis of Acute Lymphoblastic Leukemia. PubMed DOI PMC

Lilljebjörn H, Fioretos T: New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia. PubMed DOI

Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. : A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. PubMed DOI PMC

Mullighan CG, Su X, Zhang J, et al. : Deletion of PubMed DOI PMC

Boer JM, Steeghs EM, Marchante JR, et al. : Tyrosine kinase fusion genes in pediatric PubMed DOI PMC

Imamura T, Kiyokawa N, Kato M, et al. : Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan. PubMed DOI PMC

Reshmi SC, Harvey RC, Roberts KG, et al. : Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. PubMed DOI PMC

Roberts KG, Li Y, Payne-Turner D, et al. : Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. PubMed DOI PMC

Roberts KG, Morin RD, Zhang J, et al. : Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. PubMed DOI PMC

Roberts KG, Reshmi SC, Harvey RC, et al. : Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. PubMed DOI PMC

Roberts KG, Pei D, Campana D, et al. : Outcomes of children with PubMed DOI PMC

Zaliova M, Moorman AV, Cazzaniga G, et al. : Characterization of leukemias with PubMed DOI PMC

Boer JM, Marchante JR, Evans WE, et al. : PubMed DOI PMC

Arber DA, Orazi A, Hasserjian R, et al. : The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. PubMed DOI

Roberts KG, Yang YL, Payne-Turner D, et al. : Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. PubMed PMC

Lilljebjörn H, Henningsson R, Hyrenius-Wittsten A, et al. : Identification of PubMed DOI PMC

Zaliova M, Kotrova M, Bresolin S, et al. : PubMed DOI

Vaskova M, Mejstrikova E, Kalina T, et al. : Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia. PubMed DOI

Mullighan CG, Miller CBS, Su X, et al. :

Yeoh EJ, Ross ME, Shurtleff SA, et al. : Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. PubMed DOI

Liu YF, Wang BY, Zhang WN, et al. : Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia. PubMed DOI PMC

Yasuda T, Tsuzuki S, Kawazu M, et al. : Recurrent PubMed DOI

Zhang J, McCastlain K, Yoshihara H, et al. : Deregulation of PubMed DOI PMC

Clappier E, Auclerc MF, Rapion J, et al. : An intragenic PubMed DOI

Zaliova M, Zimmermannova O, Dörge P, et al. : PubMed DOI

Slamova L, Starkova J, Fronkova E, et al. : CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage. PubMed DOI

Gu Z, Churchman M, Roberts K, et al. : Genomic analyses identify recurrent PubMed DOI PMC

Hirabayashi S, Ohki K, Nakabayashi K, et al. : PubMed DOI PMC

McClure BJ, Heatley SL, Kok CH, et al. : Pre-B acute lymphoblastic leukaemia recurrent fusion, PubMed DOI PMC

Gocho Y, Kiyokawa N, Ichikawa H, et al. : A novel recurrent PubMed DOI

Hrusak O, de Haas V, Stancikova J, et al. : International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. PubMed DOI

Shago M, Abla O, Hitzler J, et al. : Frequency and outcome of pediatric acute lymphoblastic leukemia with PubMed DOI

Herglotz J, Unrau L, Hauschildt F, et al. : Essential control of early B-cell development by Mef2 transcription factors. PubMed DOI

Suzuki K, Okuno Y, Kawashima N, et al. : PubMed DOI

Harewood L, Robinson H, Harris R, et al. : Amplification of PubMed DOI

Slater R, Smit E, Kroes W, et al. : A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p1?3;q11). PubMed

Russell LJ, Enshaei A, Jones L, et al. : PubMed DOI

Hunger SP, Ohyashiki K, Toyama K, et al. : Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. PubMed DOI

Mullighan CG, Collins-Underwood JR, Phillips LA, et al. : Rearrangement of PubMed DOI PMC

Russell LJ, Capasso M, Vater I, et al. : Deregulated expression of cytokine receptor gene, PubMed DOI

Mullighan CG, Goorha S, Radtke I, et al. : Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. PubMed DOI

Rand V, Parker H, Russell LJ, et al. : Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. PubMed DOI

Hunger SP, Mullighan CG: Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. PubMed DOI PMC

Morak M, Attarbaschi A, Fischer S, et al. : Small sizes and indolent evolutionary dynamics challenge the potential role of PubMed DOI PMC

Ensor HM, Schwab C, Russell LJ, et al. : Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and PubMed DOI

Jain N, Lu X, Daver N, et al. : Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients. PubMed DOI PMC

Heerema NA, Carroll AJ, Devidas M, et al. : Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. PubMed DOI PMC

Moorman AV, Robinson H, Schwab C, et al. : Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials. PubMed DOI

Fischer U, Forster M, Rinaldi A, et al. : Genomics and drug profiling of fatal PubMed DOI PMC

Schwab C, Nebral K, Chilton L, et al. : Intragenic amplification of PubMed DOI PMC

Boer JM, den Boer ML: PubMed DOI

Yoda A, Yoda Y, Chiaretti S, et al. : Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. PubMed DOI PMC

Hertzberg L, Vendramini E, Ganmore I, et al. : Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of PubMed DOI

Bugarin C, Sarno J, Palmi C, et al. : Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia. PubMed DOI PMC

Biondi A, Schrappe M, De Lorenzo P, et al. : Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. PubMed DOI PMC

Andersson AK, Ma J, Wang J, et al. : The landscape of somatic mutations in infant PubMed DOI PMC

Holmfeldt L, Wei L, Diaz-Flores E, et al. : The genomic landscape of hypodiploid acute lymphoblastic leukemia. PubMed DOI PMC

Paulsson K, Lilljebjörn H, Biloglav A, et al. : The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. PubMed DOI

Zhang J, Mullighan CG, Harvey RC, et al. : Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. PubMed DOI PMC

Zaliova M, Hovorkova L, Vaskova M, et al. : Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16. PubMed DOI

Irving J, Matheson E, Minto L, et al. : Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. PubMed DOI PMC

Jerchel IS, Hoogkamer AQ, Ariës IM, et al. : RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia. PubMed DOI PMC

Duployez N, Grzych G, Ducourneau B, et al. : PubMed DOI PMC

Kobayashi K, Miyagawa N, Mitsui K, et al. : TKI dasatinib monotherapy for a patient with Ph-like ALL bearing PubMed DOI

Lengline E, Beldjord K, Dombret H, et al. : Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with PubMed DOI PMC

Masuzawa A, Kiyotani C, Osumi T, et al. : Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with PubMed DOI

Mayfield JR, Czuchlewski DR, Gale JM, et al. : Integration of ruxolitinib into dose-intensified therapy targeted against a novel PubMed DOI PMC

Perwein T, Strehl S, König M, et al. : Imatinib-induced long-term remission in a relapsed PubMed DOI PMC

Schwab C, Ryan SL, Chilton L, et al. : PubMed DOI

Weston BW, Hayden MA, Roberts KG, et al. : Tyrosine kinase inhibitor therapy induces remission in a patient with refractory PubMed DOI

Ding YY, Stern JW, Jubelirer TF, et al. : Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with PubMed DOI PMC

Malone A, Langabeer S, O'Marcaigh A, et al. : A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia. PubMed DOI

Yeung DT, Moulton DJ, Heatley SL, et al. : Relapse of PubMed DOI

Zhang Y, Gao Y, Zhang H, et al. : PubMed DOI PMC

Slayton WB, Schultz KR, Kairalla JA, et al. : Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622. PubMed DOI PMC

Lukes J, Jr, Potuckova E, Sramkova L, et al. : Two novel fusion genes, PubMed DOI

Zimmermannova O, Doktorova E, Stuchly J, et al. : An activating mutation of PubMed DOI PMC

Zuna J, Zaliova M, Muzikova K, et al. : Acute leukemias with PubMed DOI

Schwartzman O, Savino AM, Gombert M, et al. : Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome. PubMed DOI PMC

Clappier E, Grardel N, Bakkus M, et al. : PubMed DOI

van der Veer A, Zaliova M, Mottadelli F, et al. : PubMed DOI

Asai D, Imamura T, Suenobu S, et al. : PubMed DOI PMC

Chen IM, Harvey RC, Mullighan CG, et al. : Outcome modeling with PubMed DOI PMC

Dörge P, Meissner B, Zimmermann M, et al. : PubMed DOI PMC

Kuiper RP, Waanders E, van der Velden VH, et al. : PubMed DOI

Olsson L, Castor A, Behrendtz M, et al. : Deletions of PubMed DOI

Olsson L, Ivanov Öfverholm I, Norén-Nyström U, et al. : The clinical impact of PubMed DOI

van der Veer A, Waanders E, Pieters R, et al. : Independent prognostic value of PubMed DOI PMC

Yamashita Y, Shimada A, Yamada T, et al. : PubMed DOI

Yang YL, Hung CC, Chen JS, et al. : PubMed DOI PMC

Stanulla M, Dagdan E, Zaliova M, et al. : PubMed DOI